HeartSciences Inc. Common Stock (HSCS) is a publicly traded Healthcare sector company. As of November 6, 2026, HSCS trades at $2.83 with a market cap of $13.27M and a P/E ratio of -0.97. HSCS moved +3.56% today. Year to date, HSCS is -8.08%; over the trailing twelve months it is +3.70%. Its 52-week range spans $1.63 to $6.47. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces HSCS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for HSCS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $2.83 |
| Market Cap | $13.27M |
| P/E Ratio | -0.97 |
| EPS | $-3.21 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.47 |
| 52-Week Low | $1.63 |
| Volume | 75.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.52K |
| Net Income | $-10.26M |
| Gross Margin | 60.88% |
1 analysts cover HSCS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.